[Assessment of the treatment of glucocorticoid-induced osteoporosis].

Shogo Asano, Atsushi Suzuki

研究成果: Review article

1 引用 (Scopus)


Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

ジャーナルUnknown Journal
出版物ステータスPublished - 03-2013

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント [Assessment of the treatment of glucocorticoid-induced osteoporosis].' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用